47.561137, 7.552541
PDF / print export
Basilea
Basel, Switzerland
- Verified lead
- David Veitch
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Anti-Infectives, Oncology Development, and Partnered Specialty Therapeutics
- Review cycle
- May 2026
- Full address
- Hegenheimermattweg 167b, CH-4123 Allschwil, Switzerland
- Site coordinates
- 47.561137, 7.552541
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Basilea people page confirming David Veitch as CEO.
- Editorial note
- Allschwil anti-infectives and oncology headquarters integrating specialty therapeutics governance, clinical development systems, and partnered commercialization oversight.
Anti-Infectives, Oncology Development, and Partnered Specialty Therapeutics
Clinical-development quality systems, Specialty therapeutics governance
Allschwil anti-infectives and oncology headquarters integrating specialty therapeutics governance, clinical development systems, and partnered commercialization oversight.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated05 Jun 2026, 01:06
Company profile · Basel, Switzerland
Basilea
Anti-Infectives, Oncology Development, and Partnered Specialty Therapeutics · Clinical and partnered specialty development
Verified 14 Mar 2026 · 3 sources
Commercial
Allschwil anti-infectives and oncology headquarters integrating specialty therapeutics governance, clinical development systems, and partnered commercialization oversight.
Contact & location
- Website
- basilea.com
- Company page
- Lead
- David Veitch (verified ↗)
- Compliance
- GLP
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Clinical and partnered specialty development
- Capabilities
- Anti-Infective Development · Oncology Programs · Partnered Commercial Strategy
- Founded
- 2000
- Headcount
- 201-500
Clinical profileSTATUS: VERIFIED MARCH 2026
David Veitch
Chief Executive Officer
Full addressHegenheimermattweg 167b, CH-4123 Allschwil, Switzerland
Site coordinates47.561137, 7.552541
Review cycleMay 2026
Physical site source
Official Basilea contact page listing Hegenheimermattweg 167b, Allschwil.
Open sourceClinical and partnered specialty development
Basel, Switzerland. Anti-Infectives, Oncology Development, and Partnered Specialty Therapeutics. Review completed on 14 Mar 2026.
Swiss and EU medicinal product oversight
Clinical-development quality systems, Specialty therapeutics governance
Anti-Infectives, Oncology Development, and Partnered Specialty Therapeutics
Allschwil anti-infectives and oncology headquarters integrating specialty therapeutics governance, clinical development systems, and partnered commercialization oversight.
Editorial note
Basilea completes the Swiss specialist-development layer with a current official executive record and a focused anti-infectives/oncology profile.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Anti-Infective Development
Oncology Programs
Partnered Commercial Strategy
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Development analytics
Clinical program systems
Partner-governance infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- VERIFIED ACTIVE 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Basilea located?
- Basilea operates from Hegenheimermattweg 167b, CH-4123 Allschwil, Switzerland, Basel, Switzerland.
- Who runs Basilea?
- Basilea is led by David Veitch, Chief Executive Officer. Verified 14 Mar 2026.
- What does Basilea do?
- Allschwil anti-infectives and oncology headquarters integrating specialty therapeutics governance, clinical development systems, and partnered commercialization oversight. Core capabilities: Anti-Infective Development, Oncology Programs, Partnered Commercial Strategy.
Editorial context
Related technical briefs
Briefs that name Basel as a covered market or city.